Tislelizumab Versus Chemotherapy as Second-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma (RATIONALE-302): A Randomized Phase III StudyLin Shen, Qi Luo, Jufeng Wang et al.|Journal of Clinical Oncology|2022Cited by 306
Sweetener aspartame aggravates atherosclerosis through insulin-triggered inflammationWeijie Wu, Wenhai Sui, Sizhe Chen et al.|Cell Metabolism|2025Cited by 47
A multiple center, open-label, single-arm, phase II clinical trial of MRG002, an HER2-targeted antibody-drug conjugate, in patients with HER2-low expressing advanced or metastatic breast cancer.Zefei Jiang, Hua Yang, Tao Sun et al.|Journal of Clinical Oncology|2022Cited by 36
Quinoprotein Adducts Accumulate in the Substantia Nigra of Aged Rats and Correlate with Dopamine-Induced Toxicity in SH-SY5Y CellsNa Wang, Jiyan Ma, Yan Wang et al.|Neurochemical Research|2011Cited by 25
Silencing Prion Protein in MDA-MB-435 Breast Cancer Cells Leads to Pleiotropic Cellular Responses to Cytotoxic StimuliGuohua Yu, Jiyan Ma|PLoS ONE|2012Cited by 20